Medical risk in patients with bipolar disorder and schizophrenia

被引:155
|
作者
Newcomer, John W.
机构
[1] Washington Univ, Sch Med, Dept Psychiat Psychol & Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Ctr Clin Studies, St Louis, MO 63110 USA
关键词
D O I
10.4088/JCP.1106e16
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Patients with schizophrenia and bipolar disorder are vulnerable to developing key modifiable risk factors for cardiovascular disease, such as obesity, smoking, hypertension, dyslipidemia, and type 2 diabetes mellitus. In addition, mood stabilizers, anticonvulsants, and antipsychotic medications, which are commonly used to treat schizophrenia and bipolar disorder, have been linked to risk for adverse metabolic changes in patients. This article reviews the current literature on the prevalence of medical risk factors in the general population as well as in those patients with schizophrenia or bipolar disorder and discusses treatment strategies and lifestyle changes that patients can make in order to reduce their risks for certain diseases.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [1] The risk for schizophrenia and bipolar disorder in siblings of probands with schizophrenia and bipolar disorder
    Ösby, U
    Brandt, L
    Terenius, L
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 24 - 24
  • [2] The risk for schizophrenia and bipolar disorder in siblings to probands with schizophrenia and bipolar disorder
    Ösby, U
    Brandt, L
    Terenius, L
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 579 - 579
  • [3] Minimising the risk of diabetes in patients with schizophrenia and bipolar disorder
    Chue, Pierre
    Cheung, Raphael
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2006, 10 (02) : 105 - 116
  • [4] CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
    Rodevand, Linn
    Steen, Nils Eiel
    Quintana, Daniel
    Reponen, Elina Johanna
    Morch, Ragni Helene
    Lunding, Synve Hoffart
    Iversen, Trude
    Lagerberg, Trine V.
    Melle, Ingrid
    Andreassen, Ole A.
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S362 - S362
  • [5] Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
    Rossom, Rebecca C.
    Hooker, Stephanie A.
    O'Connor, Patrick J.
    Crain, A. Lauren
    Sperl-Hillen, Joann M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [6] METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PATIENTS WITH SCHIZOPHRENIA, BIPOLAR DISORDER AND SCHIZOAFFECTIVE DISORDER
    Munoz-Calero Franco, Paloma
    Sanchez Sanchez, Blanca
    Rodriguez Criado, Natalia
    Pinilla Santos, Berta
    Bravo Herrero, Sandra
    Cruz Fourcade, Jose Fernando
    Martin Aragon, Ruben
    NUTRICION HOSPITALARIA, 2015, 32 (06) : 2715 - 2717
  • [7] Impulsivity and Risk Taking in Bipolar Disorder and Schizophrenia
    L Felice Reddy
    Junghee Lee
    Michael C Davis
    Lori Altshuler
    David C Glahn
    David J Miklowitz
    Michael F Green
    Neuropsychopharmacology, 2014, 39 : 456 - 463
  • [8] Impulsivity and Risk Taking in Bipolar Disorder and Schizophrenia
    Reddy, L. Felice
    Lee, Junghee
    Davis, Michael C.
    Altshuler, Lori
    Glahn, David C.
    Miklowitz, David J.
    Green, Michael F.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (02) : 456 - 463
  • [9] Overall health and medical comorbidities in schizophrenia and bipolar disorder
    Beyer, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S589 - S589
  • [10] Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, Schizoaffective disorder, and bipolar disorder
    Kilbourne, Amy M.
    Brar, Jaspreet S.
    Drayer, Rebecca A.
    Xu, Xiangyan
    Post, Edward P.
    PSYCHOSOMATICS, 2007, 48 (05) : 412 - 417